Drug class
Carbothioamide antimycobacterial; second-line antituberculosis agent
Mechanism of action
A prodrug activated by the mycobacterial EthA enzyme. Its active metabolite inhibits InhA, a key enzyme in mycolic-acid synthesis required for the Mycobacterium tuberculosis cell wall.
General use cases
- Treatment of drug-resistant tuberculosis as part of an appropriately selected multidrug regimen.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
